Avammune Therapeutics

Philadelphia, PA · Founded 2017 · Privately Held (backing)

Developer of non-nucleotide small-molecule inhibitors designed for the treatment of cancer and infectious diseases. Avammune Therapeutics is based in Philadelphia, PA and was founded in 2017. Its last reported valuation was $33 million in May 2025. It has raised $18.5 million.

Last reported valuation

$33.0M

Oct 2026

Priced at

—

Total raised

$18.5M

Last round

—

How much has Avammune Therapeutics raised?

$18.5Macross 0 recorded rounds

Free account

More of Avammune Therapeutics with a free account

·Watch Avammune Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Avammune Therapeutics investors

7 investors are on record for Avammune Therapeutics, including JITO Incubation & Innovation Foundation, Shastra VC, IvyCap Ventures and The Chennai Angels.

For fundraisers

Raising for a company like Avammune Therapeutics?

7 investors have backed Avammune Therapeutics.

See all 7 investors →

Frequently asked about Avammune Therapeutics

How much has Avammune Therapeutics raised?: Avammune Therapeutics has raised $18.5M in total across 0 recorded funding rounds.